A US military program led by DARPA is modifying the stimulant drug dextroamphetamine so it can be switched on or off in the brain using near-infrared light, avoiding risks like addiction
A US military program led by DARPA is modifying the stimulant drug dextroamphetamine so it can be switched on or off in the brain using near-infrared light, avoiding risks like addiction